Attana's presentation from Erik Penser Bank's Bolagsdag is now available on Attana's website
On March 10, 2022, CEO Teodor Aastrup gave a presentation in connection with Erik Penser Bank's Bolagsdag.
The presentation gave an introduction to Attana's two business areas, Life Science and Diagnostics, as well as an update on Attana's track record in drug development and Attana's patent portfolio.
The presentation can be viewed on Attana's website by following this link:
For more information, please contact:
Teodor Aastrup, CEO
+46 (0)8 674 57 00
The Board of directors for Attana consider that the information in this press release is not likely to have a significant effect on the share price but is of general interest for the shareholders and hence should be communicated.
Attana was founded in 2002 with the vision of in vitro characterization of molecular interactions mimicking in vivo conditions. Since then, Attana has developed proprietary label free biosensors for biochemical, crude, sera, and cell-based assays and the Attana Virus Analytics (AVA) platform, a proprietary in vitro diagnostics (IVD) tool. Attana products and research services are used by Big Pharma, biotech companies and academic institutions within the life sciences. To learn more about our latest services and products, please visit www.attana.com or contact firstname.lastname@example.org